Acteoside (CAS 61276-17-3)

Acteoside, also known as Verbascoside, a natural compound found abundantly in various plants, is recognized as a phenylethanoid glycoside with remarkable properties. Renowned for its anti-inflammatory, anti-bacterial, and anti-oxidant characteristics, Acteoside has captivated scientific interest. Extensive research has explored its potential therapeutic applications, encompassing conditions such as cancer, diabetes, and Alzheimer′s disease. Moreover, Acteoside′s utility in cosmetics and food supplements has also been investigated. Biochemically and physiologically, Acteoside exhibits diverse effects. It displays inhibition of cyclooxygenase-2 (COX-2) and nuclear factor kappa B (NF-kB), mechanisms that contribute to its anti-inflammatory properties. Furthermore, Acteoside demonstrates the ability to reduce inflammation and safeguard cells against oxidative damage. Its broad spectrum of activities encompasses anti-inflammatory, anti-bacterial, and anti-oxidant actions. Notably, it has exhibited inhibitory effects on the growth of specific cancer cell lines, further underlining its potential therapeutic significance. The precise mechanism of Acteoside′s action remains a subject of ongoing investigation. Studies have unveiled its ability to impede the activity of specific enzymes, including cyclooxygenase-2 (COX-2), responsible for generating inflammatory mediators. Additionally, Acteoside can inhibit the activity of certain proteins like nuclear factor kappa B (NF-kB), which modulates the transcription of pro-inflammatory genes. As research on Acteoside continues to advance, a deeper understanding of its properties and mechanisms will emerge. This knowledge will contribute to harnessing its potential for therapeutic interventions and fostering advancements in various scientific fields, propelling the development of novel treatments and applications.